Latin America Sepsis Diagnostics Market: Estimation, Dynamics, Regional Share, Trends, Competitor Analysis (2017-2021) and Forecast (2022-2028)

$ PRICE - $ 3,000.00$ 8,900.00

Latin America Sepsis Diagnostics Market: By Product (Instruments, Blood Culture Media, Assay Kits and Reagents, Software), By Technology (Microbiology, Molecular Diagnostics, Immunoassays, Flow Cytometry), By Pathogen Type (Bacterial Sepsis [Gram-Positive Bacteria and Gram-Negative Bacteria], Fungal Sepsis, and Others), By Test Type (Laboratory Tests and Point-Of-Care Tests) and Country

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail
SKU: N/A Categories: ,

Report

Description

The Latin America Sepsis Diagnostics Market size is valued at USD 180.9 million in 2021 and is expected to grow at a significant CAGR of 7.5% during the forecast period from 2022 to 2028. The market provides a detailed overview of the market and that can be segmented By Product, Technology, Pathogen, Testing Type. By Product, the market has been segmented into Microbiology, Molecular Diagnostics, Immunoassays, Flow Cytometry. The Microbiology segment is likely to be the largest and fastest-growing segment in terms of Product. Based on pathogen type, the Latin America sepsis diagnostics market is segmented into Bacterial Sepsis, Fungal Sepsis, and Others.  Among these, the bacterial sepsis segment is expected to have the fastest-growing market during the forecast period 2022-2028. By Method, the market is segmented into Conventional Diagnostics and Automated Diagnostics. Conventional Diagnostics are expected to dominate the market in the future. Based on test type, the market has been segmented into Laboratory Tests and Point-Of-Care Tests. Laboratory Tests segment expected to grow at the highest CAGR over the forecast years. Based on the end-user, the market has been segregated into Hospitals, Pathology & Reference Laboratories. The Hospitals segment is to dominate other segments in the Latin America Sepsis Diagnostics market according to Precision Business Insights.

Key Development:

In January 2020, Roche and Inotrem SA, a France-based company, formed a strategic agreement for the commercialization of a companion diagnostics test intended for septic shock.

Latin America Sepsis Diagnostics Market

MARKET SUMMARY
-
7.5%
  • Study Period– 2022 – 2028
  • Base Year– 2021
  • CAGR– 7.5%

Latin America Sepsis Diagnostics Market

  • The latin america sepsis diagnostics market report gives comprehensive outlook across the globe with special emphasis on key regions
  • The latin america sepsis diagnostics market report gives historical, current, and future market sizes (US$ Mn) based on by product, technology, pathogen type, test type and geography.
Key Players
  • Bruker Corporation
  • Danaher Corporation
  • Roche Diagnostics
  • BioMerieux SA
  • Luminex
Latin America Sepsis Diagnostics Market Drivers

Factors such as the high prevalence of sepsis and the introduction of technologically advanced diagnostic solutions are expectesd to significantly fuel the market growth over the forecast period.


Latin America Sepsis Diagnostics Market

By country, Brazil is expected to witness highest market share during the forecast period. This growth can be attributed to the presence of a well-established healthcare infrastructure, which has led to a rise in the adoption of advanced diagnostic solutions in the country.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Features of the Report

  • The latin america sepsis diagnostics market report provides granular level information about the market size, regional market share, historic market (2017-2021) and forecast (2022-2028)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
Latin America Sepsis Diagnostics Market Segmentation


Location

GEOGRAPHY

Frequently Asked Questions

The latin america sepsis diagnostics market is projected to expand at a CAGR of 7.5% during the forecast period.

The major players in the global Latin America Sepsis Diagnostics market are Abbott Laboratories Inc., Beckman Coulter, Inc, Becton, Dickinson, and Company, BioMérieux SA, Bruker Corporation, Danaher Corporation, Luminex, Roche Diagnostics.


Report

Table Of Content

1. Executive Summary
2. Latin America Sepsis Diagnostics Market Introduction
2.1. Latin America Sepsis Diagnostics Market – Taxonomy
2.2. Latin America Sepsis Diagnostics Market –Definitions
2.2.1. Product
2.2.2. Technology
2.2.3. Pathogen
2.2.4. Testing Type
3. Latin America Sepsis Diagnostics Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Latin America Sepsis Diagnostics Market Dynamic Factors – Impact Analysis
3.6. Latin America Sepsis Diagnostics Market – Competition Landscape
4. Latin America Sepsis Diagnostics Market Analysis, 2017-2021 and Forecast, 2022-2028
4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Latin America Sepsis Diagnostics Market, By Product, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) 
5.1. Instruments
5.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Blood Culture Media
5.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Assay Kits and Reagents
5.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
5.4. Software
5.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.3. Market Opportunity Analysis
6. Latin America Sepsis Diagnostics Market Forecast, By Technology, 2017-2021 and Forecast, 2020 – 2026 (Revenue, USD Mn) 
6.1. Microbiology
6.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Molecular Diagnostics
6.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Immunoassays
6.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
6.4. Flow Cytometry
6.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.4.3. Market Opportunity Analysis
7. Latin America Sepsis Diagnostics Market Forecast, By Pathogen, 2017-2021 and Forecast, 2020 – 2026 (Revenue, USD Mn) 
7.1. Bacterial Sepsis
7.1.1. Gram-positive Bacteria
7.1.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.1.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.1.3. Market Opportunity Analysis
7.1.2. Gram-negative Bacteria
7.1.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.1.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.2.3. Market Opportunity Analysis
7.2. Fungal Sepsis
7.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Others
7.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
8. Latin America Sepsis Diagnostics Market Forecast, By Testing Type, 2017-2021 and Forecast, 2020 – 2026 (Revenue, USD Mn)
8.1. Laboratory Testing
8.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. PoC Testing
8.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
9. Latin America Sepsis Diagnostics Market Forecast, By Region, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) 
9.1. Brazil
9.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.1.3. Market Opportunity Analysis
9.2. Mexico
9.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.2.3. Market Opportunity Analysis
9.3. Argentina
9.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.3.3. Market Opportunity Analysis
9.4. Rest of Latin America
9.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.4.3. Market Opportunity Analysis
9.5. Latin America Sepsis Diagnostics Market – Opportunity Analysis Index, By Product, Technology, Pathogen, Testing Type and Country, 2022-2028
10. Brazil Perfusion Systems Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) 
10.1. Product Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1. Blood Culture Media
10.1.2. Assay Kits and Reagents
10.1.3. Software
10.2. Technology Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.2.1. Microbiology
10.2.2. Molecular Diagnostics
10.2.3. Immunoassays
10.2.4. Flow Cytometry
10.3. Pathogen Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.3.1. Bacterial Sepsis
10.3.1.1. Gram-positive Bacteria
10.3.1.2. Gram-negative Bacteria
10.3.2. Fungal Sepsis
10.3.3. Others
10.4. Testing Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.4.1. Laboratory Testing
10.4.2. PoC Testing
10.5. Brazil Perfusion Systems Market – Opportunity Analysis Index, By Product, Technology, Pathogen, Testing Type and Country, 2022-2028
10.6. Brazil Perfusion Systems Market Dynamics – Trends
11. Mexico Perfusion Systems Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) 
11.1. Product Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1. Blood Culture Media
11.1.2. Assay Kits and Reagents
11.1.3. Software
11.2. Technology Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.2.1. Microbiology
11.2.2. Molecular Diagnostics
11.2.3. Immunoassays
11.2.4. Flow Cytometry
11.3. Pathogen Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.3.1. Bacterial Sepsis
11.3.1.1. Gram-positive Bacteria
11.3.1.2. Gram-negative Bacteria
11.3.2. Fungal Sepsis
11.3.3. Others
11.4. Testing Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.4.1. Laboratory Testing
11.4.2. PoC Testing
11.5. Mexico Perfusion Systems Market – Opportunity Analysis Index, By Product, Technology, Pathogen, Testing Type and Country, 2022-2028
11.6. Mexico Perfusion Systems Market Dynamics – Trends
12. Argentina Perfusion Systems Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) 
12.1. Product Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1. Blood Culture Media
12.1.2. Assay Kits and Reagents
12.1.3. Software
12.2. Technology Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.2.1. Microbiology
12.2.2. Molecular Diagnostics
12.2.3. Immunoassays
12.2.4. Flow Cytometry
12.3. Pathogen Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.3.1. Bacterial Sepsis
12.3.1.1. Gram-positive Bacteria
12.3.1.2. Gram-negative Bacteria
12.3.2. Fungal Sepsis
12.3.3. Others
12.4. Testing Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.4.1. Laboratory Testing
12.4.2. PoC Testing
12.5. Argentina Perfusion Systems Market – Opportunity Analysis Index, By Product, Technology, Pathogen, Testing Type and Country, 2022-2028
12.6. Argentina Perfusion Systems Market Dynamics – Trends
13. Rest of Latin America Perfusion Systems Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) 
13.1. Product Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.1. Blood Culture Media
13.1.2. Assay Kits and Reagents
13.1.3. Software
13.2. Technology Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.2.1. Microbiology
13.2.2. Molecular Diagnostics
13.2.3. Immunoassays
13.2.4. Flow Cytometry
13.3. Pathogen Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.3.1. Bacterial Sepsis
13.3.1.1. Gram-positive Bacteria
13.3.1.2. Gram-negative Bacteria
13.3.2. Fungal Sepsis
13.3.3. Others
13.4. Testing Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.4.1. Laboratory Testing
13.4.2. PoC Testing
13.5. Rest of Latin America Perfusion Systems Market – Opportunity Analysis Index, By Product, Technology, Pathogen, Testing Type and Country, 2022-2028
13.6. Rest of Latin America Perfusion Systems Market Dynamics – Trends
14. Competition Landscape 
14.1. Strategic Dashboard of Top Market Players
14.2. Company Profiles (Introduction, Financial Analysis, Product & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
14.2.1. Abbott Laboratories Inc.
14.2.2. Beckman Coulter, Inc
14.2.3. Becton, Dickinson, and Company
14.2.4. BioMerieux SA
14.2.5. Bruker Corporation
14.2.6. Danaher Corporation
14.2.7. Luminex
14.2.8. Roche Diagnostics
15. Research Methodology
16. Key Assumptions and Acronyms

Report

Company Profile

  • Abbott Laboratories Inc.
  • Beckman Coulter, Inc
  • Becton, Dickinson, and Company
  • BioMerieux SA
  • Bruker Corporation
  • Danaher Corporation
  • Luminex
  • Roche Diagnostics

Description

The Latin America Sepsis Diagnostics Market size is valued at USD 180.9 million in 2021 and is expected to grow at a significant CAGR of 7.5% during the forecast period from 2022 to 2028. The market provides a detailed overview of the market and that can be segmented By Product, Technology, Pathogen, Testing Type. By Product, the market has been segmented into Microbiology, Molecular Diagnostics, Immunoassays, Flow Cytometry. The Microbiology segment is likely to be the largest and fastest-growing segment in terms of Product. Based on pathogen type, the Latin America sepsis diagnostics market is segmented into Bacterial Sepsis, Fungal Sepsis, and Others.  Among these, the bacterial sepsis segment is expected to have the fastest-growing market during the forecast period 2022-2028. By Method, the market is segmented into Conventional Diagnostics and Automated Diagnostics. Conventional Diagnostics are expected to dominate the market in the future. Based on test type, the market has been segmented into Laboratory Tests and Point-Of-Care Tests. Laboratory Tests segment expected to grow at the highest CAGR over the forecast years. Based on the end-user, the market has been segregated into Hospitals, Pathology & Reference Laboratories. The Hospitals segment is to dominate other segments in the Latin America Sepsis Diagnostics market according to Precision Business Insights.

Key Development:

In January 2020, Roche and Inotrem SA, a France-based company, formed a strategic agreement for the commercialization of a companion diagnostics test intended for septic shock.

Reviews

There are no reviews yet.

Be the first to review “Latin America Sepsis Diagnostics Market: Estimation, Dynamics, Regional Share, Trends, Competitor Analysis (2017-2021) and Forecast (2022-2028)”

Your email address will not be published. Required fields are marked *

ASIA PACIFIC OFFICE

Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX